Back to search

Article

Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer

2021-06-14

Abstract excerpt

<title>Abstract</title> <p><bold>Objective</bold>: To examine the difference in levels of fear of cancer progression (FoP), anxiety, depression between presence/absence of the target-adverse events (AEs); and to examine the differences in incidence rate of AEs and FoP, anxiety, and depression among three generations of EGFR-TKIs therapy (first, gefitinib and erlotinib [G1]; second, afatinib [G2]; third, osimertin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6ccc01a-90b0-549e-bf44-c88d47ab274a
DOI
10.21203/rs.3.rs-545027/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-545027/v1
Analysis of Influence Factors of Quality of Life of Lung Cancer Patients with Skin Adverse Drug Reactions Under Targeted TherapySemantic proximity
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.Semantic proximity
A Qualitative Research Exploring the Experiences of Patients Receiving Immune Checkpoint Inhibitors for Advanced Lung CancerSemantic proximity
Thyroid-related Adverse Events Caused by Immune Checkpoint Inhibitors Associated with Therapeutic Outcomes in Cancer Patients: a systematic review and meta-analysisSemantic proximity
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients.Semantic proximity
Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients.Semantic proximity
Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors.Semantic proximity
Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities.Semantic proximity
Anxiety and Depression of Cancer Patients: Phylosophical Review of Psychological AspectsSemantic proximity
Cutaneous adverse events associated with Rybrevant based on FDA Adverse Event Reporting System (FAERS) database from 2021 to 2024Semantic proximity
Symptom Clusters, Fear of Disease Progression and Quality of Life in Gastric Cancer Patients: A Cross-Sectional StudySemantic proximity
A double-edged sword: Should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis?Semantic proximity
Select a neighboring publication to make it the new centre.